SPOTLIGHT POSTERS

Pre-recorded poster presentations will be available on the ADC 2021 virtual platform, PheedLoop, to view at your leisure until December 31, 2021.  Section 2 MOC Program credits are available for you to claim for the poster presentations you watch – please claim directly.

P2.01   The Prognostic Value of Peripheral Blood CD4/CD8 Ratio in Mycosis Fungoides | Ching-Jung Lu, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

P2.02   Comparison of Reflectance Confocal Microscopy and Pigmented Lesion Assay as Non-invasive Tools to Diagnose Cutaneous Melanoma | Rithi Chandy, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA

P2.04   Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions | Nadia Kashetsky, Faculty of Medicine, Memorial University, St. John’s, NL, Canada

P2.05   Pityriasis Rubra Pilaris: a Bibliometric Analysis | Natalie M. Villa, Division of Dermatology, Department of Medicine. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

P2.06   Self-Learning Modules in Dermatology for the Multisystem Course at the University of Montreal’s Undergraduate Medical Program: Introduction of a Novel Educational Tool | Darosa Lim, Université de Montréal, Montréal, QC, Canada

P2.07   A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration | Hana I. Nazir, BA, Medical College of Georgia, Augusta, GA, USA

P2.08   Cancer Immunotherapy Treatment Triggers Pyoderma Gangrenosum as an Injection Site Reaction | Melissa Berman Rosa, McGill University Faculty of Medicine, Montreal, QC, Canada

P2.09   Promising Treatment of Brooke-Spiegler Syndrome (BSS): Tumor Debulking Followed by Topical Sirolimus | Stephanie Ghazal, McGill University, Montreal, QC, Canada

P2.10   A Case of Systemic Lupus Erythematosus Complicated By Refractory Discoid Lupus Erythematosus Treated With Rituximab on African American Skin | Christy Nwankwo, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA

P2.11   Use of Medical Marijuana as a Successful Treatment of Intractable Pruritus Secondary to Primary Sclerosing Cholangitis | Youkyung S. Roh, Johns Hopkins University School of Medicine, Baltimore, MD, USA

E-POSTERS

Electronic posters will be available on ADC 2021 virtual platform, PheedLoop, to view at your leisure until December 31, 2021.

P3.02   Association Between Health Insurance Status and Survival in Melanoma Patients in the United States from 2007-2016 | Claudia V. Trilles, Herbert Wertheim College of Medicine, Miami, FL, USA

P3.03   In-Hospital Mortality of Skin Melanoma and the Association of Insurance Types and Outcomes over Two Decades in the United States | Jane M. Anderson, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

P3.06   Facial lichen planus pigmentosus and frontal fibrosing alopecia in a female patient; an unusual case report | Cynthia Fournier, Laval University, Quebec, QC, Canada

P3.07   Extensive Necrotizing Fasciitis from Fournier’s Gangrene | Mona Alshehri, Ochsner Health System, New Orleans, LA, USA

P3.08   Palmoplantar Sarcoidosis: A Novel Variant Refractory to Traditional Treatment | David Nassim, McGill University, Faculty of Medicine and Health Sciences, Montreal, QC, Canada

P3.09   High Incidence of Treatment Satisfaction With Long-Term Dupilumab Treatment in Adult Patients With Moderate-To-Severe Atopic Dermatitis (LIBERTY AD OLE) | Brad Shumel, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

P3.10   Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT/QTc Intervals in Adult Healthy Volunteers | Brandon Kirsch, Kirsch Dermatology, Naples, FL, USA

P3.11   Contrasting Readability and Availability of Spanish Language with English Language Patient Resource Materials | Pavane L. Gorrepati, Massachusetts General Hospital, Boston, MA, USA

P3.12   Role of Service-learning in Dermatology Residency Programs: a National Survey of Dermatology Residents and Recent Graduates | Bansri Patel, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

P3.13   The Psychological Impact of Isotretinoin Therapy on Acne Vulgaris Patients | Randa R. Khafaji, King Saud bin Abdulaziz University for Health Sciences, Jeddah,  Saudi Arabia

P3.14   Comparing Culprit Drug Identification Methods for Cutaneous Drug Eruptions: a Scoping Review | Reetesh Bose, University of Ottawa, Ottawa, ON, Canada

P3.15   Laboratory Safety of Dupilumab in Pediatric Patients Aged ≥6 to <12 Years With Severe Atopic Dermatitis: Results From a Phase 3 Trial (LIBERTY AD PEDS) | Brad Shumel, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

P3.16   A Long-Term Safety Study to Assess Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, 9 to 16 Years of Age, with Primary Axillary Hyperhidrosis | Brandon Kirsch, Kirsch Dermatology, Naples, FL, USA

P3.17   Recurrent Angiolymphoid Hyperplasia with Eosinophilia Treated Successfully with Pulse Dye Laser Therapy | Shifa Akhtar, Florida International University Herbert Wertheim College of Medicine, Miami, FL, USA

P3.18   Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials | Michael Cronin, UCB Pharma, Raleigh, NC, USA

P3.19   Bimekizumab Treatment of Moderate to Severe Plaque Psoriasis with Scalp, Nail and Palmoplantar Involvement Through 52 Weeks: Post-Hoc Analysis from the Be Vivid Phase 3 Trial | Michael Cronin, UCB Pharma, Raleigh, NC, USA

P3.20   Bimekizumab Efficacy and Safety vs Adalimumab in Moderate to Severe Plaque Psoriasis: a Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE) | Michael Cronin, UCB Pharma, Raleigh, NC, USA

P3.22   Assessing Patient Satisfaction with Live-Interactive Teledermatology Visits During the Covid-19 Pandemic | Lu Yin, New York University Grossman School of Medicine, New York City, NY, USA

P3.23   Global Awareness, Knowledge and Practice Patterns of Psychodermatology: Results and Analysis of Studies from North America, Europe, and Asia | Rachel Christensen, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

P3.24   Health Care Workers’ Dermatology Needs During the COVID-19 Pandemic | Nicole Trepanowski, Boston University School of Medicine, Boston, MA, USA